IL-33 binding antibodies

CO20260009225A2Pending Publication Date: 2026-06-30GLAXOSMITHKLINE INTPROP DEV LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
GLAXOSMITHKLINE INTPROP DEV LTD
Filing Date
2026-06-23
Publication Date
2026-06-30
Patent Text Reader

Abstract

This disclosure relates to the treatment of interleukin (IL-33)-mediated diseases, including pulmonary diseases. In particular, this disclosure relates to IL-33-binding proteins, including anti-IL-33 antibodies, and their uses in the treatment of IL-33-mediated diseases.
Need to check novelty before this filing date? Find Prior Art